The effects of lead (Pb) administration on infection-induced decreases in water intake, food intake, and body weight gain have been assessed as manifestations of sickness behavior using a BALB/c mouse model. Pb acetate (0.5 mM) was administered via drinking water to dams from Day 0 postpartum to weaning and to mouse pups after weaning until sacrifice. At 22 days after birth, young mice were infected with Listeria monocytogenes. Mice with blood Pb levels of less than 25 µg/dl exhibited enhanced and prolonged sickness behavior compared to mice not exposed to Pb. With this mouse model, after infection, serum levels of interleukin (IL)-1β and IL-6 were enhanced in Pb-exposed mice. Compared with control infected mice, significant reductions in the number of thymic CD4 
The effects of lead (Pb) administration on infection-induced decreases in water intake, food intake, and body weight gain have been assessed as manifestations of sickness behavior using a BALB/c mouse model. Pb acetate (0.5 mM) was administered via drinking water to dams from Day 0 postpartum to weaning and to mouse pups after weaning until sacrifice. At 22 days after birth, young mice were infected with Listeria monocytogenes. Mice with blood Pb levels of less than 25 µg/dl exhibited enhanced and prolonged sickness behavior compared to mice not exposed to Pb. With this mouse model, after infection, serum levels of interleukin (IL)-1β and IL-6 were enhanced in Pb-exposed mice. Compared with control infected mice, significant reductions in the number of thymic CD4
Ϫ T cells were observed in Pb-exposed mice. As a substitute for the infection, mice were injected with IL-1 and/or IL-6; Pb exacerbated sickness behavior only in mice injected peripherally with IL-1 and IL-6. Our data in young mice suggest that children with blood Pb levels during bacterial infection may exhibit enhanced and prolonged sickness behavior due to Pb/cytokine-dependent processes and that Pb appears to influence sickness behavior depending on the types and amounts of cytokines generated.
INTRODUCTION
Lead (Pb) exposure during development has serious deleterious effects on brain functions and causes problematic behavior, hearing deficit, immunosuppression, growth retardation, and impairment of some neuromuscular functions (Lanphear, 1998; Mendelsohn, Dreyer, Fierman, Rosen, Legano, Kruger, Lim, & Courtlandt, 1998; Calderon-Salinas, Valdez-Anaya, Mazuniga-Charles, & AlboresMedina, 1996) . Pb-dependent morbidity changes are essential assessments for public health consideration since a large population of children has subclinical levels of Pb in blood and/or brain. As of 1997, 1 in every 20 children in the United States is affected by subclinical Pb toxicity, defined as a blood Pb level of 10 µg/dl or higher (CDC, 1997). In some cities, especially in the northeastern United States, more than two-thirds (68%) of preschool children have subclinical blood Pb levels (Melman, Nimeh, & Anbar, 1998) .
Studies of toxicity in children have been focused on mental development, since a 4-5% drop in an intelligence quotient was reported with an increase in Pb from 10 to 30 µg/dl of blood (Baghurst, McMichael, Wigg, Vimpani, Robertson, Roberts, & Tong, 1992) . Infections early in life also have been suggested to be associated with central nervous system (CNS) malfunctions, including mental retardation (Cannon, Rosso, Bearden, Sanchez, & Hadley, 1999; Camp, Broman, Nichols, & Leff, 1998; Grimwood, Nolan, Bond, Anderson, Catroppa, & Keir, 1996; Matilainen, Airaksinen, Mononen, Launiala, & Kaariainen, 1995; Connolly & Kvalsvig, 1993) , and Pb has been reported to decrease host resistance to numerous infectious agents (Lawrence, 1985) . In addition to direct or indirect effects on mental health, effects on intensity
